Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 63 results for "pfizer"

India will now help protect over five million children from the life-threatening Pneumococcal Disease
Business Standard

India will now help protect over five million children from th...

threatening Pneumococcal Disease New Delhi [India], May 15 (ANI-BusinessWireIndia): Pfizer announced that its 13-valent Pneumococcal Conjugate Vaccine has been selected for inclusion in India?s immunization program in select states. DNA, 1 week ago

929 images for pfizer

Reuters, 1 week ago
Reuters, 2 weeks ago
Reuters, 2 weeks ago
Reuters, 1 month ago
First Post.com, 1 month ago
Reuters, 1 month ago
Money Control, 2 months ago
catchnews.com, 2 months ago
Reuters, 2 months ago
Reuters, 2 months ago

Pfizer's pneumonia vaccine now part of immunisation programme

Drug firm Pfizer today said its pneumonia vaccine PCV 13 has been included in India's immunisation programme in select states.
 DNA2 weeks ago
Reuters

Pfizer drug from Medivation deal shows promise in breast cancer: study

(Reuters) - A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in check, according to data from a mid-stage study ...
 Reuters1 week ago Pfizer immuno-oncology drug wins U.S. approval for bladder cancer  Reuters2 weeks ago Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance  Reuters2 months ago
Sify

US STOCKS-S&P 500, Dow end session flat, tech boosts Nasdaq

* Data: Manufacturing strong, homebuilding weak, * Retailer earnings mixed * Pfizer down after Citi cuts to "sell" * Microsoft leads technology sector gainers * Dow down 0.01 pct, S&P down 0.07 pct, Nasdaq up 0.3 pct(Updates to close, adds commentary) By ...
 Sify1 week ago US STOCKS-S&P 500 falls on mixed data, Nasdaq helped by tech stocks  Sify1 week ago S&P 500, Dow end session flat, tech boosts Nasdaq  Sify1 week ago S&P 500 falls on mixed data, Nasdaq helped by tech stocks  Sify1 week ago

Doctors 'too reliant' on depression questionnaire designed by Pfizer, campaigners warn

They say patients whose symptoms may be the result of unusually stressful or traumatic episodes in their lives are being labelled clinically depressed or anxious because GPs do not have the time to conduct proper psychiatric interviews and rely too heavily on ...
 The Telegraph UK6 days ago
Sify

Drug approvals bounce back as R&D labs churn out new winners

By Ben Hirschler LONDON (Reuters) - The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.
 Sify2 days ago
Sify

US STOCKS-Wall St on track to open at record highs

* Home Depot rises on profit beat * S&P, Nasdaq closed at record levels on Monday * Futures up: Dow 33 pts, S&P 1.75 pt, Nasdaq 6.5 pts(Adds details, comments, updates prices) By Yashaswini Swamynathan May 16 (Reuters) - U.S. stocks were poised to open at ...
 Sify1 week ago Wall Street on track to open at record highs  Sify1 week ago

Pfizer Q4 net profit falls 22% to Rs 68 cr

Drug firm Pfizer today reported a 21.98 per cent dip in its standalone net profit at Rs 68.04 crore for the fourth quarter ended March 31, 2017. The company had posted a net profit of Rs 87.21 crore for the corresponding period of the previous fiscal, Pfizer ...
 Business Standard3 weeks ago

Pfizer#39;s Hospira receives 11 FDA observations for Vizag unit

An inspection by the US Food and Drug Administration took place at the sterile injectables manufacturing unit between March 9 and 17.
 Money Control2 months ago FDA warns Pfizer over contaminated drugs at Kansas plant  Reuters2 months ago
First Post.com

As AstraZeneca chases rivals, immuno-oncology gets complicated

Three years after Pfizer's failed bid for AstraZeneca, the British drugmaker aims to prove in the coming weeks that its cancer immunotherapy can deliver on bold sales forecasts made during that takeover battle. Central to AstraZeneca's case is a trial called ...
 Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less